Insight Molecular Diagnostics (IMDX) Return on Capital Employed Growth (1y) (2017 - 2026)
Insight Molecular Diagnostics (IMDX) Return on Capital Employed Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | -17.00 |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 42.00 |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 768.00 |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 44.00 |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -18.00 |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 732.00 |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -1,014.00 |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -251.00 |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 109.00 |
| 10 | Insight Molecular Diagnostics | 158.03 Mn | 139.50 Mn | 157,000.00 | -9,227.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9,227.00 |
| Mar 31, 2026 | -9,846.00 |
| Dec 31, 2025 | -8,928.00 |
| Sep 30, 2025 | -8,568.00 |
| Jun 30, 2025 | -7,452.00 |
| Mar 31, 2025 | -9,252.00 |
| Dec 31, 2024 | -9,985.00 |
| Sep 30, 2024 | -4,236.00 |
| Jun 30, 2024 | -3,584.00 |
| Mar 31, 2024 | -5,117.00 |
| Dec 31, 2023 | -1,995.00 |
| Sep 30, 2023 | 86.00 |
| Jun 30, 2023 | 1,693.00 |
| Mar 31, 2023 | 3,627.00 |
| Dec 31, 2022 | 3,410.00 |
| Sep 30, 2022 | 30.00 |
| Jun 30, 2022 | -929.00 |
| Mar 31, 2022 | -792.00 |
| Dec 31, 2021 | 1,288.00 |
| Sep 30, 2021 | 3,178.00 |